Clinical Trials Logo

Clinical Trial Summary

Evaluation of sensitivity of Sentinel lymph nodes for detecting nodal metastases in cervical cancer


Clinical Trial Description

Consecutive women with stage 1a2-2a1 cervical cancer scheduled for surgery will be approached for eligibility by defined criteria.

Sentinel nodes will be detected by a combined use of Indocyanine green and Tc99 radiocolloid ( first 75 patients) and for the continuation with either the combined use or the best performing of those tracers.

Technical success rates, adverse events (related study intervention and overall) sensitivity and negative predictive values will be estimated.

An interim analyse will be performed after 34 node positive patients based on the Fleming two stage analyse. The null hypothesis of sensitivity of 85% will be tested against an estimated sensitivity of 95%. At this stage the study may be closed for futility, closed as hull hypothesis is rejected or continued to reach another 28 node positive patients.

As a full pelvic lymphadenectomy will be performed after detection of sentinel nodes patient will act ast their own controls. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03680833
Study type Interventional
Source Region Skane
Contact Jan Persson, ass professor
Phone +46733522080
Email jan.persson@med.lu.se
Status Recruiting
Phase N/A
Start date June 15, 2014
Completion date December 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03719833 - Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer Patents
Recruiting NCT00654342 - Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer N/A
Not yet recruiting NCT04140188 - SLNB After Nipple Sparing Mastectomy N/A
Recruiting NCT01564264 - Sentinel Node Biopsy in Endometrial Cancer N/A
Recruiting NCT06212440 - Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy N/A
Terminated NCT03630653 - Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer Relapse N/A
Completed NCT03833960 - SLNB After Neoadjuvant Treatment in Node Positive Patients
Active, not recruiting NCT04986306 - The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients
Recruiting NCT05512468 - Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant Chemotherapy N/A
Recruiting NCT03199560 - Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy Phase 4
Not yet recruiting NCT04932460 - Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy N/A
Completed NCT03200704 - A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer Phase 3
Recruiting NCT04403867 - The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.
Not yet recruiting NCT05703295 - Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients
Enrolling by invitation NCT05942170 - The Combination of Preoperative MRI and SLN in the Surgical Management of CC and EC N/A
Recruiting NCT03937414 - Intraoperative Molecular Diagnosis of Sentinel Lymph Node In Breast Cancer Patients N/A
Recruiting NCT06120439 - Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy N/A
Terminated NCT05457842 - A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery Phase 2